Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions. It is involved in developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, or IPF, and levodopa-induced dyskinesia, or LID, in patients with Parkinson's disease.
Quote | Trevi Therapeutics Inc. (NASDAQ:TRVI)
Last: | $3.10 |
---|---|
Change Percent: | -4.62% |
Open: | $3.25 |
Close: | $3.25 |
High: | $3.27 |
Low: | $3.1 |
Volume: | 70,972 |
Last Trade Date Time: | 07/29/2024 03:00:00 am |
News | Trevi Therapeutics Inc. (NASDAQ:TRVI)
Trevi Therapeutics to Participate in Upcoming Investor and Healthcare Events PR Newswire Two abstracts accepted for oral presentation at the 13 th London International Cough Symposium NEW HAVEN, Conn. , July 2, 2024 /PRNewswire/ -- Trevi Therapeutic...
2024-05-11 13:56:10 ET Trevi Therapeutics, Inc. (TRVI) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Jennifer Good - President and Chief Executive Officer Lisa Delfini - Chief Financial Officer David Clark - Chief Medical Officer ...
Message Board Posts | Trevi Therapeutics Inc. (NASDAQ:TRVI)
Subject | By | Source | When |
---|---|---|---|
TRVI....................................https://stockcharts.com/h-sc/ui?s=TRVI&p | glenn1919 | investorshub | 04/22/2023 12:14:27 PM |
Uptick Network: $TRVI Trevi Therapeutics, Inc. News ~ Progress & 2022 Success of Clinical Studies fo | Uptick Network | investorshangout | 02/07/2023 4:50:35 PM |
Uptick Network: $TRVI updates! Trevi Therapeutics, Inc. Discusses Progress and 2022 Success of Clini | Uptick Network | investorshangout | 01/31/2023 10:58:24 AM |
Uptick Network: $TRVI News out! Trevi Therapeutics, Inc. ~ Progress and 2022 Success of Clinical Stu | Uptick Network | investorshangout | 01/30/2023 12:10:25 PM |
Uptick Network: $TRVI Trevi Therapeutics, Inc. Discusses Progress and 2022 Success of Clinical Studi | Uptick Network | investorshangout | 01/25/2023 5:41:17 PM |
News, Short Squeeze, Breakout and More Instantly...
Trevi Therapeutics Inc. Company Name:
TRVI Stock Symbol:
NASDAQ Market:
Trevi Therapeutics Inc. Website:
Trevi Therapeutics to Participate in Upcoming Investor and Healthcare Events PR Newswire Two abstracts accepted for oral presentation at the 13 th London International Cough Symposium NEW HAVEN, Conn. , July 2, 2024 /PRNewswire/ -- Trevi Therapeutic...
Trevi Therapeutics to Participate in Upcoming Conferences PR Newswire NEW HAVEN, Conn. , May 9, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™...
Trevi Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates PR Newswire Reaffirms guidance for the Phase 2a RIVER trial in refractory chronic cough and Human Abuse Potential (HAP) Study with topline data for each expected in the second half of...